• Medical Policies

    Premera offers access to more than 300 medical policies online. Since we’re continually updating these pages, we encourage you to visit often. The policies are in Adobe PDF format. Individual plans use different medical policies. View individual plan medical policies and also View our HMO medical policies.

    Enter one or more keywords. Enter "policy" to see a complete list of policies.

* One or more keywords are required

  Reset search
447 results found for policy
https://www.premera.com/medicalpolicies/5.01.660.pdf#search=policy
PHARMACY POLICY - 5.01.660 Inhaled Corticosteroids Effective Date: Jan. 1, 2026 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/6.01.54.pdf#search=policy
MEDICAL POLICY - 6.01.54 Dopamine Transporter Single-Photon Emission Computed Tomography BCBSA Ref. Policy: 6.01.54 Effective Date: Jan. 1, 2026 Last Revised: Dec. 8, 2025 ...
https://www.premera.com/medicalpolicies/6.01.68.pdf#search=policy
MEDICAL POLICY - 6.01.68 Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney, Lung, or Prostate BCBSA Ref. Policy: 6.01.68 Effective Date: Jan. 1, 2026 ...
https://www.premera.com/medicalpolicies/10.01.512.pdf#search=policy
MEDICAL POLICY - 10.01.512 Ambulance and Medical Transport Services Effective Date: Feb. ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/15.01.001.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.001 Allergen Testing Ref. Policy: G2031 Effective Date: Feb. 6, 2026 Last Revised: Feb. 6, 2026 Replaces: N/A RELATED POLICIES: 15.01.036 ...
https://www.premera.com/medicalpolicies/2.01.544.pdf#search=policy
MEDICAL POLICY - 2.01.544 Transurethral Water Vapor Thermal Therapy and Transurethral Water Jet Ablation for Benign Prostatic Hyperplasia BCBSA Ref. Policy: 2.01.49 Effective Date: ...
https://www.premera.com/medicalpolicies/5.01.584.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.584 CGRP Inhibitors for Migraine Prophylaxis BCBSA Ref. Policy: 5.01.29 Effective Date: Nov. 1, 2025 Last Revised: Oct. 14, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/5.01.589.pdf#search=policy
PHARMACY POLICY - 5.01.589 BRAF and MEK Inhibitors Effective Date: Mar. 1, 2026 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.595.pdf#search=policy
PHARMACY/MEDICAL POLICY - 5.01.595 Injectable Clostridial Collagenase for Fibroproliferative Disorders BCBSA Ref. Policy: 5.01.19 Effective Date: Apr. 1, 2025 Last Revised: Mar. ...
https://www.premera.com/medicalpolicies/7.01.142.pdf#search=policy
MEDICAL POLICY - 7.01.142 Surgery for Groin Pain in Athletes BCBSA Ref. Policy: 7.01.142 Effective Date: May 1, 2025 Last Revised: Apr. 7, 2025 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/7.01.583.pdf#search=policy
MEDICAL POLICY - 7.01.583 Amniotic Membrane and Amniotic Fluid BCBSA Ref. Policy: 7.01.149 Effective Date: Jul. 1, 2025 Last Revised: Jan. 1, 2026 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/7.01.588.pdf#search=policy
MEDICAL POLICY - 7.01.588 Percutaneous Electrical Nerve Stimulation and Percutaneous Neuromodulation Therapy BCBSA Ref. Policy: 7.01.29 Effective Date: Sep. 1, 2025 Last Revised: ...
https://www.premera.com/medicalpolicies/7.01.592.pdf#search=policy
MEDICAL POLICY - 7.01.592 Surgical Treatment of Femoroacetabular Impingement BCBSA Ref. Policy: 7.01.118 Effective Date: Jul. 1, 2025 Last Revised: Jun. 23, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/7.03.07.pdf#search=policy
MEDICAL POLICY - 7.03.07 Lung and Lobar Lung Transplant BCBSA Ref. Policy: 7.03.07 Effective Date: Dec. 1, 2025 Last Revised: Nov. 10, 2025 Replaces: Extracted from 7.03.509 ...
https://www.premera.com/medicalpolicies/8.01.531.pdf#search=policy
MEDICAL POLICY - 8.01.531 Hematopoietic Cell Transplantation for Waldenström Macroglobulinemia BCBSA Ref. Policy: 8.01.54 Effective Date: Oct. 1, 2025 Last Revised: Sep. 8, 2025 ...
https://www.premera.com/medicalpolicies/8.01.62.pdf#search=policy
MEDICAL POLICY - 8.01.62 Electronic Brachytherapy for Nonmelanoma Skin Cancer BCBSA Ref. Policy: 8.01.62 Effective Date: Oct. 1, 2025 Last Revised: Jan. 1, 2026 Replaces: N/A ...
https://www.premera.com/medicalpolicies/5.01.613.pdf#search=policy
PHARMACY POLICY - 5.01.613 Oral Iron Chelating Agents BCBSA Ref. Policy: 8.01.02 Effective Date: Mar. 1, 2025 Last Revised: Feb. 24, 2025 Replaces: N/A RELATED MEDICAL POLICIES: ...
https://www.premera.com/medicalpolicies/5.01.627.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.627 Thymic Stromal Lymphopoietin (TSLP) Inhibitors ... Medical Necessity criteria within this policy DOES NOT apply to Alaska fully- insured ...
https://www.premera.com/medicalpolicies/5.01.658.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.658 Denosumab Products Effective Date: Mar. 1, 2026 Last ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/1.01.29.pdf#search=policy
MEDICAL POLICY - 1.01.29 Tumor Treating Fields Therapy BCBSA Ref. Policy: 1.01.29 Effective Date: Dec. 1, 2025 Last Revised: Feb. 10, 2026 Replaces: N/A RELATED MEDICAL POLICIES: ...